SIX1 and oral cavity squamous cell carcinoma: It was also demonstrated that miR‐188 inhibited oral squamous cell carcinoma by targeting SIX1, offering new insights into the detailed molecular mechanisms of oral squamous cell carcinoma (Wang & Liu, 2016).